Syed M. J. Kazmi

Chief Executive Officer at Jubilant Therapeutics, Inc.

67 year

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Joaquin Duato	M	61	JOHNSON & JOHNSON	35 years
Todd Davis	M	63	LIGAND PHARMACEUTICALS INCORPORATED	17 years
John Kozarich	M	74	LIGAND PHARMACEUTICALS INCORPORATED	21 years
John LaMattina	M	74	LIGAND PHARMACEUTICALS INCORPORATED	13 years
Stephen Sabba	M	64	LIGAND PHARMACEUTICALS INCORPORATED	16 years
Jason Aryeh	M	55	LIGAND PHARMACEUTICALS INCORPORATED	18 years
Hari Shankar Bhartia	M	67	Jubilant Therapeutics, Inc. Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ.	-
Robert Glassman	M	62	Jubilant Therapeutics, Inc. Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ.	3 years
Nadir Patel	M	54	Jubilant Therapeutics, Inc. Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ.	1 years
Pramod Yadav	M	60	Jubilant Therapeutics, Inc. Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ.	-
Leila Alland	M	61	Jubilant Therapeutics, Inc. Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ.	3 years
Kathryn Wengel	F	58	JOHNSON & JOHNSON	36 years
Mitch Guss	M	-	Jubilant Therapeutics, Inc. Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ.	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Alex Gorsky	M	63	JOHNSON & JOHNSON	35 years
Michael H. Ullmann	M	66	JOHNSON & JOHNSON	33 years
John Higgins	M	54	LIGAND PHARMACEUTICALS INCORPORATED	15 years
John Johnson	M	66	JOHNSON & JOHNSON	19 years
Jack L. Bowman	M	91	JOHNSON & JOHNSON	7 years
Robert E. Campbell	M	90	JOHNSON & JOHNSON	36 years
Melanie J. Herman	F	45	LIGAND PHARMACEUTICALS INCORPORATED	5 years
Sunil Patel	M	52	LIGAND PHARMACEUTICALS INCORPORATED	-
Nishan de Silva	M	51	LIGAND PHARMACEUTICALS INCORPORATED	3 years
William A. Pettit	M	-	LIGAND PHARMACEUTICALS INCORPORATED	-
David Knott	M	79	LIGAND PHARMACEUTICALS INCORPORATED	-
David Eric Robinson	M	-	LIGAND PHARMACEUTICALS INCORPORATED	-
James Cullen	M	81	JOHNSON & JOHNSON	20 years
Charles Berkman	M	55	LIGAND PHARMACEUTICALS INCORPORATED	21 years
Tom Manion	M	70	JOHNSON & JOHNSON	8 years
Warner R. Broaddus	M	-	LIGAND PHARMACEUTICALS INCORPORATED	6 years
Matthew Foehr	M	51	LIGAND PHARMACEUTICALS INCORPORATED	11 years
David John Bailey	M	75	JOHNSON & JOHNSON	-
Pierre B. Pirard	M	56	JOHNSON & JOHNSON	15 years
Robin T. Barney	F	62	JOHNSON & JOHNSON	-
Andrew Maslaveckas	M	-	JOHNSON & JOHNSON	-
Robert O’Holla	M	72	JOHNSON & JOHNSON	18 years
Richard Ghalie	M	66	LIGAND PHARMACEUTICALS INCORPORATED	4 years
Gerald Ostrov	M	73	JOHNSON & JOHNSON	15 years
David C. Furlano	M	-	LIGAND PHARMACEUTICALS INCORPORATED	5 years
Miguel Patricio	M	57	JOHNSON & JOHNSON	6 years
Kevin Mosher	M	-	JOHNSON & JOHNSON	4 years
Louis J. Scotti	M	68	LIGAND PHARMACEUTICALS INCORPORATED	2 years
Michelle Harrison	M	-	JOHNSON & JOHNSON	3 years
JoAnn Heffernan Heisen	F	74	JOHNSON & JOHNSON	-
William McComb	M	61	JOHNSON & JOHNSON	14 years
Ken Berlin	M	59	JOHNSON & JOHNSON	13 years
Geert Cauwenbergh	M	70	JOHNSON & JOHNSON	8 years
Mark Erlander	M	64	JOHNSON & JOHNSON	6 years
Janice M. Smiell	M	-	JOHNSON & JOHNSON	9 years
Chris Calabretta	M	-	JOHNSON & JOHNSON	26 years
Noreen Dishart	F	-	JOHNSON & JOHNSON	7 years
Duncan Fatkin	M	-	JOHNSON & JOHNSON	11 years
Angelo Scopelianos	M	69	JOHNSON & JOHNSON	24 years
Marianne de Backer	M	55	JOHNSON & JOHNSON	28 years
Bill Doyle	M	61	JOHNSON & JOHNSON	5 years
Tomas Jan Heyman	M	68	JOHNSON & JOHNSON	23 years
Manuel Aguero	M	62	JOHNSON & JOHNSON	6 years
Patrick W. McNallen	M	-	JOHNSON & JOHNSON	2 years
David Duerst	M	-	JOHNSON & JOHNSON	11 years
Mike Werner	M	-	JOHNSON & JOHNSON	2 years
Andrea J. Casper	F	-	JOHNSON & JOHNSON	-
Sennen Pamich	M	-	JOHNSON & JOHNSON	6 years
Ray Ogle	M	-	JOHNSON & JOHNSON	-
Jack Butler	M	-	JOHNSON & JOHNSON	7 years
Christopher J. Stergion	M	58	JOHNSON & JOHNSON	15 years
Alan Kerzner	M	-	JOHNSON & JOHNSON	4 years
Steven J. Burakoff	M	81	LIGAND PHARMACEUTICALS INCORPORATED	2 years
Ivan Delevic	M	59	JOHNSON & JOHNSON	4 years
Gerard N. Burrow	M	-	JOHNSON & JOHNSON	12 years
Jean-Luc Butel	M	67	JOHNSON & JOHNSON	6 years
Martin D. Meglasson	M	74	LIGAND PHARMACEUTICALS INCORPORATED	6 years
Arnold G. Langbo	M	86	JOHNSON & JOHNSON	19 years
Karen Prange	F	60	JOHNSON & JOHNSON	17 years
George A. Ziets	M	77	JOHNSON & JOHNSON	7 years
Jessica Stone Rampton	F	53	LIGAND PHARMACEUTICALS INCORPORATED	5 years
Peter D. Bewley	M	77	JOHNSON & JOHNSON	17 years
Andrew Dahlkemper	M	57	JOHNSON & JOHNSON	4 years
Maria Bedoya-Toro Munera	M	72	LIGAND PHARMACEUTICALS INCORPORATED	3 years
Paul J. Guagliardo	M	-	JOHNSON & JOHNSON	3 years
Brigette Roberts	M	-	LIGAND PHARMACEUTICALS INCORPORATED	2 years
Patrick M. Lonergan	M	89	JOHNSON & JOHNSON	30 years
Kathleen A. McGowan	F	63	JOHNSON & JOHNSON	12 years
Maxine Frank Singer	M	-	JOHNSON & JOHNSON	12 years
William W. Crouse	M	80	JOHNSON & JOHNSON	-
Kenneth G. Hayes	M	-	JOHNSON & JOHNSON	17 years
Michael C. Chen	M	74	JOHNSON & JOHNSON	9 years
Marc Wipperman	M	-	JOHNSON & JOHNSON	19 years
Arlene Morris	F	72	JOHNSON & JOHNSON	16 years
David M. Clapper	M	72	JOHNSON & JOHNSON	16 years
Ron Hunt	M	59	JOHNSON & JOHNSON	7 years
John Steven Sonnier	M	-	JOHNSON & JOHNSON	7 years
Per A. Peterson	M	79	JOHNSON & JOHNSON	13 years
James J. L'Italien	M	71	LIGAND PHARMACEUTICALS INCORPORATED	5 years
Carl C. Peck	M	-	LIGAND PHARMACEUTICALS INCORPORATED	10 years
Bruno A. Melzi	M	76	JOHNSON & JOHNSON	10 years
Daniel Loeb	M	62	LIGAND PHARMACEUTICALS INCORPORATED	2 years
Thomas M. Tully	M	78	JOHNSON & JOHNSON	8 years
Taylor J. Crouch	M	64	LIGAND PHARMACEUTICALS INCORPORATED	2 years
Thomas H. Silberg	M	76	LIGAND PHARMACEUTICALS INCORPORATED	3 years
Nadav Friedmann	M	81	JOHNSON & JOHNSON	11 years
Alan Dunton	M	70	JOHNSON & JOHNSON	7 years

Statistics

Country	Connections	% of total
United States	100	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections